Neurogene

About:

Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.

Website: https://www.neurogene.com/

Top Investors: BlackRock, Alexandria Venture Investments, Cormorant Asset Management, Samsara BioCapital, RTW Investments

Description:

Neurogene is a developer of generic medicines intended to improve patient outcomes for neurological disorders.The company's offerings include advancing genetic medicines for many neurological disorders where no effective treatment options exist, providing patients and families affected by rare neurological disorders with gene therapy that improves quality of life.